Bayer urged to restart compassionate use program of Kogenate

Published: 2011-07-29 06:58:00
Updated: 2011-07-29 06:58:00
A local hemophiliac group has called for Bayer to re-initiate their compassionate use program of Kogenate FS, antihemophilic factor (recombinant) for 21 Korean patients.

Kogenate is a recombinant factor VIII treatment indicated for the control and prevention of bleeding episodes and peri-opera...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.



Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.